Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 1,043.15
+3.55 (0.34%)
Sep 11, 2025, 2:30 PM IST
Zydus Lifesciences Employees
Zydus Lifesciences had 27,917 employees as of March 31, 2025. The number of employees increased by 996 or 3.70% compared to the previous year.
Employees
27,917
Change (1Y)
996
Growth (1Y)
3.70%
Revenue / Employee
8.46M INR
Profits / Employee
1.64M INR
Market Cap
1,046.08B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27,917 | 996 | 3.70% |
| Mar 31, 2024 | 26,921 | 3,895 | 16.92% |
| Mar 31, 2023 | 23,026 | -717 | -3.02% |
| Mar 31, 2022 | 23,743 | -669 | -2.74% |
| Mar 31, 2021 | 24,412 | -588 | -2.35% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Apollo Hospitals Enterprise | 42,497 |
| Mankind Pharma | 26,978 |
| Fortis Healthcare | 12,237 |
| Alkem Laboratories | 18,785 |
| Aurobindo Pharma | 27,707 |
Zydus Lifesciences News
- 16 hours ago - Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Benzinga
- 6 days ago - Zydus Lifesciences shares jump over 2% as subsidiary enters into licensing and supply agreement with Synthon BV - Business Upturn
- 6 days ago - Top stocks to watch today, September 5: HDFC Life, HCLTech, Zydus Lifesciences, Bharat Forge and more - Business Upturn
- 6 days ago - Stocks to watch today, Sept 5: Sterlite Tech, JB Chemicals, Bharat Forge, Zydus Lifesciences, Varun Beverages in focus - Business Upturn
- 6 days ago - ICMR issues licences to industry partners for 9 breakthrough techs - The Times of India
- 6 days ago - Zydus enters exclusive licensing deal with Synthon for Ozanimod capsules in US market - Business Upturn
- 9 days ago - Zydus Lifesciences launches VaxiFlu trivalent influenza vaccine for flu protection in India - Business Upturn
- 12 days ago - Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis - Business Upturn